A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ)

類似資料

• Open-Label, Single-Dose, Parallel-Group Study in Healthy Volunteers To Determine the Drug-Drug Interaction Potential between KAE609 (Cipargamin) and Piperaquine
  著者:: Stein, Daniel S., 等
  出版事項: (2015)
• Spiroindolone KAE609 for Falciparum and Vivax Malaria
  著者:: White, Nicholas J., 等
  出版事項: (2014)
• A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
  著者:: Leong, F. Joel, 等
  出版事項: (2014)
• Pharmacokinetic-Pharmacodynamic Analysis of Spiroindolone Analogs and KAE609 in a Murine Malaria Model
  著者:: Lakshminarayana, Suresh B., 等
  出版事項: (2015)
• A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine
  著者:: Leong, F. Joel, 等
  出版事項: (2018)